Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jon C. Anders"'
Autor:
Charles L. Loprinzi, Drew K. Seisler, Patricia C. Griffin, Michelle A. Neben Wittich, Jeff A. Sloan, Robert C. Miller, David Schwartz, Brandon Birckhead, James D. Bearden, Rex B. Mowat, Robert E. Haselow, Pamela J. Atherton, James A. Martenson, Roscoe F. Morton, Jon C. Anders, Thomas J. Stoffel, Terence T. Sio
Radiotherapy-related dermatological toxicities over time have not been well quantified. We examined during and immediately following radiation therapy skin toxicities over time in a randomized study of mometasone furoate vs placebo during breast radi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d298f8f4aa1da4b823dde8d4a01d8383
https://europepmc.org/articles/PMC4967382/
https://europepmc.org/articles/PMC4967382/
Autor:
Charles D. Hechtman, David B. Mansur, Joseph R. Simpson, Cindy A. Palucci, Jon C. Anders, Zuofeng Li, Robert J. Myerson, Catherine S Wu, Carlos A. Perez
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 63:961-968
Purpose: To evaluate the dose distribution outside of a cyst instilled with phosphorous-32 (P-32, an electron emitter with a short effective range of 2–8 mm and average energy of 0.69 MeV, used to treat cystic craniopharyngioma) as a function of cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::599240f5b0304ecd210d472813489589
https://doi.org/10.1016/j.ijrobp.2004.12.071
https://doi.org/10.1016/j.ijrobp.2004.12.071
Autor:
David Schwartz, Richard L. Deming, Patricia C. Griffin, Kelli N. Burger, Jon C. Anders, Jeff A. Sloan, Michelle A. Neben-Wittich, Pamela J. Atherton, James A. Martenson, Charles L. Loprinzi, Robert C. Miller
Publikováno v:
International journal of radiation oncology, biology, physics. 81(2)
Purpose Considerable interobserver variability exists among providers and between providers and patients when measuring subjective symptoms. In the recently published Phase III N06C4 trial of mometasone cream vs. placebo to prevent radiation dermatit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab88120c78e60f42841cb1441163741b
https://pubmed.ncbi.nlm.nih.gov/20888137
https://pubmed.ncbi.nlm.nih.gov/20888137
Autor:
Jeff A. Sloan, Robert C. Miller, James D. Bearden, Charles L. Loprinzi, Patricia C. Griffin, Paul L. Schaefer, David Schwartz, Jon C. Anders, Thomas J. Stoffel, Richard L. Deming, Robert E. Haselow, Pamela J. Atherton, James A. Martenson
Publikováno v:
International journal of radiation oncology, biology, physics. 79(5)
Purpose A two-arm, double-blind, randomized trial was performed to evaluate the effect of 0.1% mometasone furoate (MMF) on acute skin-related toxicity in patients undergoing breast or chest wall radiotherapy. Methods and Materials Patients with ducta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1280424405729894197fdbab2857444
https://pubmed.ncbi.nlm.nih.gov/20800381
https://pubmed.ncbi.nlm.nih.gov/20800381
Publikováno v:
Radiation Oncology (London, England)
Radiation Oncology, Vol 1, Iss 1, p 14 (2006)
Radiation Oncology, Vol 1, Iss 1, p 14 (2006)
Background The risk of severe cardiovascular toxicity, specifically thromboembolic events (TE), in patients with cervical cancer receiving concurrent irradiation and cisplatin chemotherapy is reported to be less than 1% in several large prospective t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d116d6e907e62e6e3427e10e26088383
https://doi.org/10.1186/1748-717x-1-14
https://doi.org/10.1186/1748-717x-1-14